Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FBXW7 |
Variant | S668fs |
Impact List | frameshift |
Protein Effect | unknown |
Gene Variant Descriptions | FBXW7 S668fs results in a change in the amino acid sequence of the Fbxw7 protein beginning at aa 668 of 707, likely resulting in premature truncation of the functional protein (UniProt.org). S668fs has been identified in sequencing studies (PMID: 26373574, PMID: 30412912, PMID: 30239046), but has not been biochemically characterized and therefore, its effect on Fbxw7 protein function is unknown (PubMed, Oct 2024). |
Associated Drug Resistance | |
Category Variants Paths |
FBXW7 mutant FBXW7 S668fs |
Transcript | NM_033632.3 |
gDNA | chr4:g.(152323003_152323004) |
cDNA | c.(2002_2001) |
Protein | p.S668fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_011532083 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
NM_033632.3 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
XM_024454122.1 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
XM_047415900.1 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
XM_024454124.1 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
XM_011532084 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
XM_047415898.1 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
XM_011532084.3 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
XM_024454123.2 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
NM_033632 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
XM_011532085.3 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
NM_033632.3 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
XM_017008362 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
XM_047415901.1 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
XM_011532085 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
XM_024454121.1 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
NM_001349798.1 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
NM_001349798.2 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
XM_047415897.1 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
XM_024454123.1 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
XM_011532085.2 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
XM_011532084.2 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
XM_047415899.1 | chr4:g.(152323003_152323004) | c.(2002_2001) | p.S668fs | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|